Sifi Mexico – Juan José Davidovich, General Manager
Juan José Davidovich, general manager of the Italian ophthalmology leader Sifi, speaks about the importance of Mexico as a base to enter Latin America and sets the goal of prospering…
SIFI has made the history of ophthalmology in Italy and has worked in the eye care sector since 1935. Italian market leader for over 15 years, it develops, produces and markets innovative pharmaceutical treatments, tools for diagnosis and surgical devices for prevention and care of the most common ocular pathologies. Since its foundation in 1935, SIFI has displayed a constant commitment to working alongside ophthalmologists. Being close to practitioners, sharing their passion for EyeCare and contributing to the improvement of disease management in ophthalmology is indeed SIFI’s principal concern. The development plans for Latin America has included the constitution in 2007 of a fully owned subsidiary, Laboratorios SIFI de México, which aims to become one of the main players in the local ophthalmic pharmaceutical sector.
Contact details
SIFI de México
Dante 36, Piso 11, Oficina 1101
Col. Anzures, Del. Miguel Hidalgo
CP 11590 México DF
MÉXICO
Tel: +52 (55) 5263 2450
Website: www.sifi.it
Juan José Davidovich, general manager of the Italian ophthalmology leader Sifi, speaks about the importance of Mexico as a base to enter Latin America and sets the goal of prospering…
We understand that Mexico has a lot of advantages for holding clinical trials, including the large population, access to specialized patient populations, higher patient retention rates and cheaper costs by…
You took over BOMI as President and CEO only last year. Could you give us a brief background on BOMI Mexico and yourself? BOMI Mexico was founded in 1995. The…
Over ten years ago, the economic concept of the ‘BRIC’ countries- Brazil, Russia, India and China – was formed, and it’s pretty much all we’ve heard about ever since.…
Despite being in the Mexican market for over twenty years, biosimilars have never been regulated as a separate entity. They have always been regulated as simply another category of generic…
We read in an article by El Economista last year that you believe “there is no other company with such a diverse range of therapies as MSD and that makes…
First of all, can you tell us about the history of Andromaco and what have been its major milestones and challenges over the years? This year marks the eightieth anniversary…
Gelpharma started in 1999 and its main strength lies in manufacturing. Please can you give us a more detailed history of the company and its major milestones since opening? We…
First of all, congratulations on the new distribution warehouse in Lerma, State of Mexico . You mentioned that there were two more to come: can you give us a bit…
The company Cryopharma was founded in 1954 with 10 employees. Today, you have fantastic facilities here in the state of Jalisco, and have grown the company to an entire group…
There have been a lot of changes in the Mexican pharmaceutical industry in the last four to five years, most notably the new drug registration process being put in place.…
Sanofi acquired Kendrick in 2009. Obviously the thinking behind it was to diversify your products into pure generics, but what were the expectations for the move? We have a diversified…
Mexico is number one in child obesity and number two in adult obesity in the world. This is one of the reasons that diabetes is rapidly increasing and the Mexican…
See our Cookie Privacy Policy Here
